Skip to search formSkip to main contentSkip to account menu

AN 207

Known as: AN-207 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Specific receptors for luteinizing hormone-releasing hormone (LH-RH), somatostatin, bombesin, and other peptides are found on… 
Review
2005
Review
2005
Chemotherapy is one of the main modalities in the therapy of cancer. However, an improvement in the efficacy and a reduction in… 
Review
2005
Review
2005
Abstract Targeted chemotherapy is a modern approach aimed at increasing the efficacy of systemic chemotherapy and reducing its… 
Review
2004
Review
2004
2000
2000
A highly potent derivative of doxorubicin, 2-pyrrolinodoxorubicin (AN-201), was linked to [D-Lys6]luteinizing hormone-releasing… 
Review
1999
Review
1999
In view of non-specific toxicity of most chemotherapeutic agents against normal cells, the development of targeted chemotherapy… 
1999
1999
BACKGROUND Receptors for luteinizing hormone-releasing hormone (LH-RH) found in prostate cancers might be used for targeting of… 
1999
1999
Receptors for luteinizing hormone‐releasing hormone (LH‐RH) found in prostate cancers might be used for targeting of… 
Highly Cited
1996
Highly Cited
1996
Doxorubicin (DOX) and its daunosamine-modified derivative, 2-pyrrolino-DOX, which is 500-1000 times more active than DOX, were…